Keito Suto
Sapporo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Immunocomplex capture fluorescence analysis for donor selection in HLA-haploidentical peripheral blood stem cell transplantation.
Journal: Transplant immunology
Published: April 02, 2026
PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation.
Journal: Leukemia
Published: December 28, 2025
Correction: Genome-wide CRISPR screen identifies MAD2L1BP and ANAPC15 as targets for brentuximab vedotin sensitivity in CD30+ peripheral T-cell lymphoma.
Journal: Leukemia
Published: November 10, 2025
Safety and Efficacy of Graft-versus-Host Disease Prophylaxis with Mini-Dose Methotrexate in Umbilical Cord Blood Transplantation: An NJHSG-CBT18 Observational Study.
Journal: Transplantation and cellular therapy
Published: August 25, 2025
Epidermotropic Methotrexate-Associated Diffuse Large B-Cell Lymphoma Presenting With Disseminated Papular Eruptions.
Journal: The Journal of dermatology
Published: July 01, 2025
Genome-wide CRISPR screen identifies MAD2L1BP and ANAPC15 as targets for brentuximab vedotin sensitivity in CD30+ peripheral T-cell lymphoma.
Journal: Leukemia
Published: March 19, 2024
Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study Group.
Journal: Haematologica
Published: December 09, 2023
Aleukemic Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia with E1A3 BCR-ABL1 Fusion Transcript.
Journal: Internal medicine (Tokyo, Japan)
Published: September 13, 2021
Extramedullary hematopoiesis of the cranial dura.
Journal: International journal of hematology
Published: October 10, 2020
Last Updated: 09/26/2026